{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:07:51Z","timestamp":1783044471185,"version":"3.54.6"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T00:00:00Z","timestamp":1139270400000},"content-version":"vor","delay-in-days":2839,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1111\/j.1749-6632.1998.tb11022.x","type":"journal-article","created":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T10:01:57Z","timestamp":1139306517000},"page":"811-816","source":"Crossref","is-referenced-by-count":39,"title":["3,4\u2010Diaminopyridine (DAP) in the Treatment of Lambert\u2010Eaton Myasthenic Syndrome (LEMS)<sup>a<\/sup>"],"prefix":"10.1111","volume":"841","author":[{"given":"DONALD B.","family":"SANDERS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,2,7]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800901)46:5<1123::AID-CNCR2820460508>3.0.CO;2-L"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1982.tb03242.x"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.10.1552"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.26.10.944"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1974.00490320072012"},{"key":"e_1_2_9_7_2","first-page":"570","volume":"11","author":"Dau P C","year":"1982","journal-title":"Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome Ann Neurol"},{"key":"e_1_2_9_8_2","first-page":"480","volume":"34","author":"Newsom\u2010Davis J","year":"1984","journal-title":"Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome Neurology"},{"key":"e_1_2_9_9_2","unstructured":"Illa I. M Codina P Salisachs & J Pradas 1986 Plasmapheresis and prednisone in Lambert\u2010Eaton syndrome Muscle Nerve9:155."},{"key":"e_1_2_9_10_2","first-page":"629","volume":"103","author":"Jost W H.","year":"1991","journal-title":"Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison Wien Klin Wochenschr"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.7.1422"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.3.678"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1993.tb04205.x"},{"key":"e_1_2_9_14_2","first-page":"1413","volume":"5","author":"Thesleff S","year":"1980","journal-title":"Aminopyridines and synaptic transmission Neuroscience"},{"key":"e_1_2_9_15_2","first-page":"95","volume":"35","author":"Molg\u00f3 J","year":"1982","journal-title":"Effects of aminopyridines on neuromuscular transmission Adv Biosci"},{"key":"e_1_2_9_16_2","first-page":"260","volume":"227","author":"Thomsen R H","year":"1983","journal-title":"Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction J Pharmacol Exp Ther"},{"key":"e_1_2_9_17_2","first-page":"112","volume":"3","author":"Kim Y I.","year":"1980","journal-title":"Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states Muscle Nerve"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.40.11.1109"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/50.4.383"},{"key":"e_1_2_9_20_2","first-page":"978","volume":"43","author":"Sanders D B.","year":"1980","journal-title":"Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_9_21_2","first-page":"265","volume":"31","author":"Murray N M F","year":"1981","journal-title":"Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission Neurology"},{"key":"e_1_2_9_22_2","first-page":"287","volume":"35","author":"Lundh H","year":"1982","journal-title":"Therapeutic applications of aminopyridines in diseases of neuromuscular transmission Adv Biosci"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912073212303"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb22949.x"},{"key":"e_1_2_9_25_2","unstructured":"Newsom\u2010Davis J 1986 Treatment of neuromuscular junction disorders: current status and new frontiers Muscle Nerve9(suppl.): 14."},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.10.1324"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00386054"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.12.1069"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-0101(87)90166-8"},{"key":"e_1_2_9_30_2","first-page":"379","article-title":"Human type A botulism and treatment with 3,4\u2010diaminopyridine","volume":"32","author":"Davis L E.","year":"1992","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"e_1_2_9_31_2","first-page":"1202","article-title":"3,4\u2010Diaminopyridine effects on compound muscle action amplitudes in a patient with botulism","volume":"15","author":"Howard J F.","year":"1992","journal-title":"Muscle Nerve"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.82"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.46.7.684"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.9.1052"},{"key":"e_1_2_9_35_2","first-page":"345","article-title":"Toxicit\u00e9 aigu\u00eb composee dequelques aminopyridines in vivo (souris) et in vitro (cultures cellulaires)","volume":"26","author":"Lechat P.","year":"1968","journal-title":"Ann Pharm Fr"},{"key":"e_1_2_9_36_2","first-page":"413","article-title":"Pharmacology of 3,4\u2010diaminopyridine","volume":"150","author":"Vohra M M","year":"1964","journal-title":"Arch Int Pharmacodyn Ther"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.1998.tb11022.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.1998.tb11022.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T08:56:27Z","timestamp":1695632187000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.1998.tb11022.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1111\/j.1749-6632.1998.tb11022.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb11022.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}